Andrew Makrides, CEO at BOVIE MEDICAL CORP (BVX), sold 47,500 shares at $7.20 ($341K) on 2009-05-21, disclosed to the SEC on 2009-05-26.
Open-market sale of $341k BVX by CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $7.20 | 39,000 | $281K | 82.3% |
| 2 | $7.09 | 8,500 | $60K | 17.7% |
| Total | $7.18 avg | 47,500 | $341K | 100% |
| Filing → |